CTABF
CANNTAB THERAPEUTICS LTD by Canntab Therapeutics Ltd (CTABF)
$
00About CANNTAB THERAPEUTICS LTD by Canntab Therapeutics Ltd (CTABF)
Canntab Therapeutics Ltd. is a biopharmaceutical company. It engages in the manufacturing and distribution of a suite of hard pill cannabinoid formulations in multiple doses and timed-release combinations. The firm's products include nanoemulsion technology, multi-particulate drug delivery systems, specialty gel capsules, propriety granulation technology, oral quick dissolve tablet, instant release solid oral, extended release solid oral, and bi-layer solid oral. The company was founded by Richard Goldstein and Jeffrey W. Renwick on May 31, 2010 and is headquartered in Markham, Canada.
Details
Daily high
--
Daily low
--
Price at open
--
52 Week High
$0.01
52 Week Low
$0.00
Market cap
--
Dividend yield
0.00%
Volume
--
Avg. volume
0
P/E ratio
--
CANNTAB THERAPEUTICS LTD by Canntab Therapeutics Ltd News
Details
Daily high
--
Daily low
--
Price at open
--
52 Week High
$0.01
52 Week Low
$0.00
Market cap
--
Dividend yield
0.00%
Volume
--
Avg. volume
0
P/E ratio
--